Efficacy, safety and immunogenicity of GP2015, an...

Efficacy, safety and immunogenicity of GP2015, an etanercept biosimilar, compared with the reference etanercept in patients with moderate-to-severe rheumatoid arthritis: 24-week results from the comparative phase III, randomised, double-blind EQUIRA study

Matucci-Cerinic, Marco, Allanore, Yannick, Kavanaugh, Arthur, Buch, Maya H, Schulze-Koops, Hendrik, Kucharz, Eugeniusz J, Woehling, Heike, Babic, Goran, Poetzl, Johann, Davis, Adanna, Schwebig, Arnd
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
4
Language:
english
Journal:
RMD Open
DOI:
10.1136/rmdopen-2018-000757
Date:
November, 2018
File:
PDF, 823 KB
english, 2018
Conversion to is in progress
Conversion to is failed